Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Licensing revenues				$ 675
Operating expenses:
Research and development	3,045	3,372	14,726	8,669
General and administrative	3,206	2,566	8,130	6,467
Total operating expenses	6,251	5,938	22,856	15,136
Loss from operations	(6,251)	(5,938)	(22,856)	(14,461)
Other income (expenses):
Interest income	416	227	947	475
Interest expense	(15)	(18)	(51)	(63)
Change in fair value of warrant liability	1,754	1,396	6,756	(8,697)
Total other income (expenses)	2,155	1,605	7,652	(8,285)
Net loss	(4,096)	(4,333)	(15,204)	(22,746)
Net loss attributable to common stockholders	$ (4,096)	$ (4,405)	$ (16,299)	$ (23,613)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (0.05)	$ (0.13)	$ (0.3)	$ (1.12)
Net income (loss) per share attributable to common stockholders, diluted (in Dollars per share)	$ (0.05)	$ (0.13)	$ (0.3)	$ (1.12)
Weighted-average shares outstanding used in computing net loss per share, basic (in Shares)	88,943,212	32,633,074	54,073,701	21,100,206
Weighted-average shares outstanding used in computing net income (loss) per share, diluted (in Shares)	88,943,212	32,633,074	54,073,701	21,100,206
Series A-1 Preferred Stockholders
Other income (expenses):
Deemed dividends to Series A-1 preferred stockholders		$ (72)		$ (867)
Series B Holders
Other income (expenses):
Cash dividends to Series B-1 preferred stockholders			$ (1,095)